Back to Search
PETER DICORLETO, M.D.
M.D.
Internal Medicine Physician
NPI: 1811985815IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
22875(CT)28537(TN)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE
Class of 1979
Research & Publications (20)
Histone H3 as a novel substrate for MAP kinase phosphatase-1.
PMID 19020052·Am J Physiol Cell Physiol·2009
7-preclinical
Fibulin-4 regulates expression of the tropoelastin gene and consequent elastic-fibre formation by human fibroblasts.
PMID 19627254·Biochem J·2009
7-preclinical
Arginase blockade lessens endothelial dysfunction after thrombosis.
PMID 18486420·J Vasc Surg·2008
7-preclinical
Adenosine prompts the heart to recruit endothelial progenitors.
PMID 18276925·Circ Res·2008
7-preclinical
ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways.
PMID 18174464·Circ Res·2008
8-other
VEGF and thrombin induce MKP-1 through distinct signaling pathways: role for MKP-1 in endothelial cell migration.
PMID 18003751·Am J Physiol Cell Physiol·2008
4-observational
Decreased atherosclerosis in mice deficient in tumor necrosis factor-alpha receptor-II (p75).
PMID 17301316·Arterioscler Thromb Vasc Biol·2007
7-preclinical
HOXA9 participates in the transcriptional activation of E-selectin in endothelial cells.
PMID 17452460·Mol Cell Biol·2007
8-other
Tumor necrosis factor alpha (TNF-alpha) receptor-II is required for TNF-alpha-induced leukocyte-endothelial interaction in vivo.
PMID 17068152·Blood·2007
7-preclinical
Lymphangiogenesis by blind-ended vessel sprouting is concurrent with hemangiogenesis by vascular splitting.
PMID 16489601·Anat Rec A Discov Mol Cell Evol Biol·2006
7-preclinical
Inhibition of p53 response in tumor stroma improves efficacy of anticancer treatment by increasing antiangiogenic effects of chemotherapy and radiotherapy in mice.
PMID 17018587·Cancer Res·2006
7-preclinical
Intra-arterial adenoviral mediated tumor transfection in a novel model of cancer gene therapy.
PMID 16899125·Mol Cancer·2006
7-preclinical
A VEGF165-induced phenotypic switch from increased vessel density to increased vessel diameter and increased endothelial NOS activity.
PMID 16872639·Microvasc Res·2006
7-preclinical
Arginase activity is increased by thrombin: a mechanism for endothelial dysfunction in arterial thrombosis.
PMID 17116549·J Am Coll Surg·2006
8-other
Thrombospondin-1 up-regulates expression of cell adhesion molecules and promotes monocyte binding to endothelium.
PMID 15833768·FASEB J·2005
8-other
Role of CL-100, a dual specificity phosphatase, in thrombin-induced endothelial cell activation.
PMID 15339908·J Biol Chem·2004
8-other
Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy.
PMID 15145120·J Am Coll Cardiol·2004
4-observational
Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome.
PMID 14961121·Nature·2004
7-preclinical
Regulated release of L13a from the 60S ribosomal subunit as a mechanism of transcript-specific translational control.
PMID 14567916·Cell·2003
8-other
Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.
PMID 12957092·Lancet·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1832 WARD DR, SUITE 102
MURFREESBORO, TN 37129 - Phone
- (615) 893-0790
Quick Facts
- NPI
- 1811985815
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 47
- Publications
- 20
Are you this provider?
Claim Your Profile